Stocks and Investing
Stocks and Investing
Mon, November 3, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, October 31, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Risinger Maintained (TEVA) at Hold with Increased Target to $61 on, Oct 31st, 2014
David Risinger of Morgan Stanley, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $57 to $61 on, Oct 31st, 2014.
David has made no other calls on TEVA in the last 4 months.
There is 1 other peer that has a rating on TEVA. Out of the 1 peers that are also analyzing TEVA, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Chris Schott of "JP Morgan" Maintained at Hold with Increased Target to $58 on, Monday, July 28th, 2014